Search results for: Precision Medicine

Medicine

What is the importance of medicine? Why is medicine a hot topic? Medicine holds enduring significance due to its pivotal role in healthcare, benefiting various stakeholders involved in development, distribution,…

Reimagining Prevention for a Healthier, More Prosperous Society: Webinar Insights

7 December 2023

…prevention programmes are tailored to the end user, thereby maximising engagement, and efficacy. Precision medicine may catalyse efficiency in prevention. Accessibility of targeted services can be supported by digital health…

Ethical and Economic Issues in the Appraisal of Medicines for Ultra-rare (or Ultra-orphan) Conditions

13 January 2020

…for medicines for more common conditions, may not be appropriate for medicines for ultra-rare conditions. Previous OHE research on availability and access to medicines for rare conditions (also known as…

Value and Cancer: Journal of Cancer Policy Special Issue

25 January 2017

…the value of a prevented fatality. The third article, authored by Professors Adrian Towse and Lou Garrison, focuses on precision cancer medicine. Lou Garrison was recently appointed as an OHE Senior…

OHE Involved in Developing New AMS Report on Stratified Medicines

15 July 2013

…and Economics of Drug Development in 2022. London: Office of Health Economics. Prof Towse’s analysis of valuing stratified/personalised medicine is contained in this short video: Challenges in valuing genomic medicines….

OHE at the 2019 Health Technology Assessment International (HTAi) Annual Meeting

7 June 2019

…paper, co-authored by Adrian, proposes principles to support dynamic efficiency in the development, adoption, and use of personalised and precision medicine. These principles define the need for a broader concept…

Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?

12 April 2024

…Intellectual Property. [online] Available at: https://www.efpia.eu/about-medicines/development-of-medicines/intellectual-property/ [Accessed 11 Apr. 2024]. European Medicines Agency and Sonia Ribeiro, 2018. Data exclusivity, market protection, orphan and paediatric rewards. [online] Available at: https://www.ema.europa.eu/en/documents/presentation/presentation-data-exclusivity-market-protection-orphan-and-paediatric-rewards-s-ribeiro_en.pdf [Accessed 5 Apr. 2024]. European…

Forecasting the Challenges and Economics of Drug Development in 2022

9 July 2013

…this publication. 1. Health care will be radically transformed as “precision” medicines plug into the specific genetic makeup of both patients and diseases, paired with increasingly powerful and convenient diagnostics….

Meeting the Challenges of Drug Development in 2022: Summary of OHE’s 50th Anniversary Conference

11 October 2012

…practical application after approval as well, as personalised medicine (also called “stratified” or “precision” medicine) enhances the prospects for treating patients more effectively and safely.  At the same time, however, many diseases with…